年轻女性乳腺癌按雌激素受体和孕激素受体状态分类的危险因素
Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status.
作者信息
McCredie M R E, Dite G S, Southey M C, Venter D J, Giles G G, Hopper J L
机构信息
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
出版信息
Br J Cancer. 2003 Nov 3;89(9):1661-3. doi: 10.1038/sj.bjc.6601293.
Abstract
We used data from 765 cases and 564 controls in the population-based Australian Breast Cancer Family Study to investigate whether, in women under the age of 40, the profile of risk factors differed between breast cancer subtypes defined by joint oestrogen and progesterone receptor status. As hypothesised, no significant differences were found.
摘要
我们利用基于人群的澳大利亚乳腺癌家族研究中765例病例和564例对照的数据，调查40岁以下女性中，联合雌激素和孕激素受体状态所定义的乳腺癌亚型之间危险因素的情况是否存在差异。正如所假设的那样，未发现显著差异。
相似文献
1
Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status.
Br J Cancer. 2003 Nov 3;89(9):1661-3. doi: 10.1038/sj.bjc.6601293.
2
Understanding Oestrogen Receptor Function in Breast Cancer and its Interaction with the Progesterone Receptor. New Preclinical Findings and their Clinical Implications.
Clin Oncol (R Coll Radiol). 2016 Jan;28(1):1-3. doi: 10.1016/j.clon.2015.10.005. Epub 2015 Nov 6.
3
Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis.
Am J Epidemiol. 1997 Aug 15;146(4):307-14. doi: 10.1093/oxfordjournals.aje.a009271.
4
Frequency of distribution of oestrogen and progesterone receptors positivities in breast cancer cases in Benin-City, Nigeria.
Niger Postgrad Med J. 2012 Mar;19(1):19-24.
5
Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.
J Clin Pathol. 1996 Nov;49(11):920-5. doi: 10.1136/jcp.49.11.920.
6
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x.
7
p53 protein expression and oestrogen and progesterone receptor status in invasive ductal breast carcinomas.
Cytopathology. 2001 Jun;12(3):197-202. doi: 10.1046/j.1365-2303.2001.00315.x.
8
The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
J Clin Pathol. 2009 Jan;62(1):95-6. doi: 10.1136/jcp.2008.060723.
9
Letter to the Editor regarding the paper by Aurilio et al., A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.
Eur J Cancer. 2014 Mar;50(5):1035-7. doi: 10.1016/j.ejca.2014.01.013. Epub 2014 Jan 31.
10
Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
Genet Epidemiol. 1996;13(2):207-21. doi: 10.1002/(SICI)1098-2272(1996)13:2<207::AID-GEPI6>3.0.CO;2-4.
引用本文的文献
1
Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis.
Int J Environ Res Public Health. 2022 Nov 21;19(22):15363. doi: 10.3390/ijerph192215363.
2
Oncobiology and treatment of breast cancer in young women.
Cancer Metastasis Rev. 2022 Sep;41(3):749-770. doi: 10.1007/s10555-022-10034-6. Epub 2022 Apr 30.
3
Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies.
Cancers (Basel). 2022 Jan 23;14(3):574. doi: 10.3390/cancers14030574.
4
A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the Swedish women's lifestyle and health cohort.
BMC Cancer. 2019 Aug 14;19(1):807. doi: 10.1186/s12885-019-5985-6.
5
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.
Int J Cancer. 2019 Dec 15;145(12):3207-3217. doi: 10.1002/ijc.32214. Epub 2019 Mar 5.
6
Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
PLoS One. 2018 Nov 7;13(11):e0205034. doi: 10.1371/journal.pone.0205034. eCollection 2018.
7
Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
Int J Cancer. 2018 Jun 1;142(11):2293-2302. doi: 10.1002/ijc.31266. Epub 2018 Feb 7.
8
Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.
Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):270-277. doi: 10.1158/1055-9965.EPI-16-0692. Epub 2016 Oct 18.
9
FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population.
Am J Cancer Res. 2015 Apr 15;5(5):1854-61. eCollection 2015.
10
Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women.
Springerplus. 2014 Dec 11;3:727. doi: 10.1186/2193-1801-3-727. eCollection 2014.
本文引用的文献
1
Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.
J Natl Cancer Inst. 2003 Mar 19;95(6):448-57. doi: 10.1093/jnci/95.6.448.
2
Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age.
Am J Epidemiol. 2002 Sep 15;156(6):507-16. doi: 10.1093/aje/kwf065.
3
Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.
J Clin Oncol. 2000 Nov 1;18(21 Suppl):107S-12S.
4
Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).
J Natl Cancer Inst Monogr. 1999(26):95-100. doi: 10.1093/oxfordjournals.jncimonographs.a024232.
5
Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.
Am J Epidemiol. 2000 Apr 1;151(7):703-14. doi: 10.1093/oxfordjournals.aje.a010265.
6
The shape of age-incidence curves of female breast cancer by hormone-receptor status.
Cancer Causes Control. 1999 Oct;10(5):431-7. doi: 10.1023/a:1008970121595.
7
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
Cancer Res. 1999 Apr 15;59(8):2011-7.
8
Breast cancer in Australian women under the age of 40.
Cancer Causes Control. 1998 Mar;9(2):189-98. doi: 10.1023/a:1008886328352.
9
Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?
Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):319-26.
10
Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance.
Acta Oncol. 1988;27(1):1-19. doi: 10.3109/02841868809090312.
Zotero 插件